Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03755-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Raquel Sánchez-Vañó und 9 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Nuclear, Hospital Universitario La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Neuroblastoma, Nuclear Medicine, Radionuclide Imaging, Practice Guidelines as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Recordati.
Abstract (Originalsprache)
Neuroblastoma (NB) is the most common extracranial solid cancer in children. Despite intensive multimodality treatment, long-term survival of patients with high-risk NB, which comprises more than half of all cases, remains poor. Nuclear medicine is key in diagnosis, staging, response assessment and long-term follow-up of NB. The emergence of novel tracers and the increasing complexity of studies require updated guidelines for nuclear medicine imaging in NB. Standardising diagnostic techniques are essential for improving study comparability and ensuring test quality. This article aims to provide a comprehensive review of NB radionuclide diagnostic imaging, including its characteristics, accuracy, advantages, and limitations. It offers practical recommendations to multidisciplinary teams responsible for treating patients with NB. This review summarises the opinions of leading experts from the Neuroblastoma Spanish Group within the Spanish Society of Paediatric Haematology and Oncology (SEHOP) and the Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Medicina Nuclear, Hospital Universitario La Fe, Valencia, Spain.
- Servicio de Hemato-Oncología Pediátrica, Hospital Universitario La Fe and Polytechnic Hospital, Valencia, Spain. balaguer_jul@gva.es.
- Servicio de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Seville, Spain.
- Servicio de Medicina Nuclear, Hospital Universitario Cruces, Barakaldo, Spain.
- Servicio de Medicina Nuclear, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
- Servicio de Hemato-Oncología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Förderung
- Recordati
Zitieren
APA
Sánchez-Vañó, R., Balaguer, J., Borrego-Dorado, I., Esteban-Figueruelo, A., Gámez, C., Hladun, R., López-Almaraz, R., Llempén, M. L., Rodado, S., & Rubio-Aparicio, P. M. (2024). Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03755-3
Vancouver
Sánchez-Vañó R, Balaguer J, Borrego-Dorado I, Esteban-Figueruelo A, Gámez C, Hladun R, et al. Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03755-3
BibTeX
@article{SnchezVa2024,
author = {Sánchez-Vañó, Raquel and Balaguer, Julia and Borrego-Dorado, Isabel and Esteban-Figueruelo, Alba and Gámez, Cristina and Hladun, Raquel and López-Almaraz, Ricardo and Llempén, Mercedes L and Rodado, Sonia and Rubio-Aparicio, Pedro M},
title = {Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03755-3}
}
EUVIMED